Yuan Yuan

Also affiliated with Cedars-Sinai Medical Center, Southwest University of Science and Technology, The University of Texas MD Anderson Cancer Center, Central South University, Capital Medical University, Peking University, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Jishuitan Hospital, City of Hope, Southeast Asia University, The First People's Hospital of Guiyang, Hangzhou Red Cross Hospital, Guizhou Provincial People's Hospital, First Affiliated Hospital of Jinan University, Taiyuan University of Technology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification”.

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of Clinical Oncology(2022)10.1200/jco.22.00830

N/A

2.2DataRank · unranked

97 citations

Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal +15 more

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002084

N/A

1.3DataRank · unranked

32 citations

Weihua Guo, Susan E. Yost, Jin Sun Lee, D. L. ROSE, Christian Avalos +7 more

Analysis of Gut Microbiome Using Explainable Machine Learning Predicts Risk of Diarrhea Associated With Tyrosine Kinase Inhibitor Neratinib: A Pilot Study

Frontiers in Oncology(2021)10.3389/fonc.2021.604584

N/A

1.0DataRank · unranked

32 citations

Susan E. Yost, Jin Sun Lee, John D. Gillece, Megan Folkerts, Lauren Reining +5 more

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y

N/A

0.809DataRank · unranked

22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer

The Oncologist(2023)10.1093/oncolo/oyad026

N/A

0.580DataRank · unranked

14 citations

Susan E. Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang +10 more

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.020

N/A

0.430DataRank · unranked

7 citations

Jin Sun Lee, Susan E. Yost, Tracey Stiller, M. Suzette Blanchard, Simran Padam +13 more

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231210675

N/A

0.296DataRank · unranked

5 citations

Colt A. Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Pei‐Cheng Lin, Helen Chang +17 more

Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.19.456799

N/A

0DataRank · unranked

0 citations

Kalyan Banda, Pooja Kumar, Robert F. Straub, Lacey E. Dobrolecki, Isabel V. Rodriguez +10 more

Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth

Nature Cell Biology(2022)10.1038/s41556-022-00919-7

N/A

0DataRank · unranked

133 citations

Roi Isaac, Wei Yan, Xianhui Ruan, Li Jiang, Yuhao Wan +24 more

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer

JCI Insight(2022)10.1172/jci.insight.153963

N/A

0DataRank · unranked

47 citations

Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, Min Hui Lim +13 more

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Cancers(2022)10.3390/cancers14174279

N/A

0DataRank · unranked

12 citations

Susan E. Yost, Jin Sun Lee, Paul Frankel, Christopher Ruel, Yujie Cui +13 more

Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1060

N/A

0DataRank · unranked

2 citations

Carolyn E. Behrendt, Susan E. Yost, Niki Patel, Raynald Samoa, Daphne Stewart +6 more

Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions

International Journal of Molecular Sciences(2023)10.3390/ijms241813726

N/A

0DataRank · unranked

60 citations

Jin Sun Lee, Xiaojiang Cui, Yuan Yuan, Cynthia Mark

CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions

International Journal of Molecular Sciences(2023)10.3390/ijms241411791

N/A

0DataRank · unranked

24 citations

Hannah Hackbart, Xiaojiang Cui, Yuan Yuan, Jin Sun Lee

Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer

Journal of Clinical Medicine(2023)10.3390/jcm12051906

N/A

0DataRank · unranked

4 citations

Sayeh Lavasani, Leon Cristobal, Niki Tank Patel, Mina S. Sedrak, Daphne Stewart +10 more

Medication-Related Osteonecrosis of the Jaw: Successful Medical Management of Complex Maxillary Alveolus with Sinus Involvement

Case Reports in Oncology(2023)10.1159/000529502

N/A

0DataRank · unranked

11 citations

Praveen Arany, Susan E. Yost, Yuan Yuan, Joel B. Epstein

937 Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple negative breast cancers

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0937

N/A

0DataRank · unranked

0 citations

Colt A. Egelston, Katherine E. Hutchinson, Jennifer M. Giltnane, Veronica Ibarra, Bonnie Liu +4 more

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Nature Cancer(2024)10.1038/s43018-024-00729-w

N/A

0DataRank · unranked

47 citations

Won Jin Ho, Ludmila Danilova, Joseph A. Tandurella, James M. Leatherman, Christine I. Rafie +22 more

Association of Structural Maintenance of Chromosome-1A Phosphorylation with Progression of Breast Cancer

Cells(2025)10.3390/cells14020128

N/A

0DataRank · unranked

2 citations

Claudia Kowolik, Daniel Schmolze, Yuan Yuan, Min Lin, Arthur D. Riggs +2 more

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach

Frontiers in Physiology(2020)10.3389/fphys.2020.511071

N/A

0DataRank · unranked

12 citations

Xuefei Li, Ting-Fang He, Tina Gruosso, Dongmei Zuo, Margarita Souleimanova +10 more

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.27.661875

N/A

0DataRank · unranked

0 citations

Sumeet Patiyal, Lipika R. Pal, Tiangen Chang, Sumona Biswas, Saugato Rahman Dhruba +36 more

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer

The Oncologist(2020)10.1002/onco.13574

N/A

0DataRank · unranked

43 citations

Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel +17 more

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis

PLoS ONE(2020)10.1371/journal.pone.0229955

N/A

0DataRank · unranked

33 citations

Susan E. Yost, Paul Frankel, Andrew Dagis, Yu Cao, Roger Wang +8 more

Strategies to Improve Participation of Older Adults in Cancer Research

Journal of Clinical Medicine(2020)10.3390/jcm9051571

N/A

0DataRank · unranked

30 citations

Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, William Dale +15 more

Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations

Future Science OA(2020)10.2144/fsoa-2020-0159

N/A

0DataRank · unranked

2 citations

Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke +14 more

Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative

Cancer(2021)10.1002/cncr.33407

N/A

0DataRank · unranked

6 citations

Kathy Pan, Joanne Mortimer, Rowan T. Chlebowski, Juhua Luo, Jessica Yan +12 more

Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.14.426737

N/A

0DataRank · unranked

2 citations

Jinfeng Chen, Onalisa Winblad, Anne O’Dea, Priyanka Sharma, Meghna S. Trivedi +13 more